MASSARI, Fabio Marcello
 Distribuzione geografica
Continente #
NA - Nord America 236
EU - Europa 70
AS - Asia 29
AF - Africa 2
Totale 337
Nazione #
US - Stati Uniti d'America 230
IT - Italia 50
CN - Cina 11
IN - India 10
SE - Svezia 8
SG - Singapore 6
CA - Canada 5
GB - Regno Unito 4
BG - Bulgaria 2
DE - Germania 2
FI - Finlandia 2
JP - Giappone 2
EG - Egitto 1
HR - Croazia 1
MX - Messico 1
NL - Olanda 1
TG - Togo 1
Totale 337
Città #
Fairfield 53
Ashburn 28
Woodbridge 24
Houston 21
Wilmington 19
Rome 15
Chandler 14
Seattle 13
Cambridge 10
Beijing 9
Milan 8
San Paolo di Civitate 8
Civitavecchia 7
Lawrence 4
New York 4
Ottawa 4
Princeton 4
Singapore 4
Ann Arbor 3
San Diego 3
Andover 2
Boston 2
Helsinki 2
Jinan 2
Millbury 2
Redwood City 2
Sofia 2
Tokyo 2
Bremen 1
Cairo 1
Dolianova 1
Edinburgh 1
Kundan 1
Lomé 1
Mexico City 1
Norwalk 1
Phoenix 1
Plano 1
Pravisdomini 1
Sassari 1
Southend 1
Toronto 1
Zagreb 1
Totale 286
Nome #
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban. rivaroxaban evaluation in real life setting (RIVER) 92
INfluenza vaccine indication during therapy with Immune checkpoint inhibitors: a transversal challenge. the INVIDIa study 89
Adjuvant treatment for resected renal cell carcinoma. Are all strategies equally negative? Potential implications for trial design with targeted agents 71
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 61
null 33
Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program 21
Totale 367
Categoria #
all - tutte 838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 5 0 9 9 27 19 20 21 19 14 13 19
2020/202137 7 3 3 5 4 3 0 0 3 6 3 0
2021/202242 0 3 6 1 4 0 1 4 2 4 10 7
2022/202365 8 14 2 9 4 13 0 10 3 0 2 0
2023/202438 3 3 2 7 5 7 0 3 0 3 3 2
Totale 367